Initially, the expression of TWIST1, SLUG, and SIP1 was evaluated individually and compared to patient data from the Brazilian National Cancer Institute cohort, which is a strictly selected cohort of invasive ductal carcinoma (IDC) containing all the relevant clinicopathological information (Table 2). This evidence concerns the gene TWIST1 and invasive ductal breast carcinoma.